Association between hyperglycemia and the development of chemotherapy induced peripheral neuropathy among patients with breast cancer in the control trial
In this analysis, hyperglycemia affected almost half of patients with CIPN versus about a third of patients without CIPN. Patients with CIPN also had higher mean glucose levels compared to those without CIPN, though the differences were not significant. No conclusions can be drawn from these results and further research is needed to assess these trends in a larger prospective patient population.
Authors
- Khadija Faheem
- Margaux Wooster (ORCID: https://orcid.org/0000-0003-3957-6093)
- Miriam Pearl Klahr
- Melissa Accordino (ORCID: https://orcid.org/0000-0002-4156-7279)
- Rohit Raghunathan
- Dawn L. Hershman (ORCID: https://orcid.org/0000-0001-8807-153X)
Institutions
- Columbia University Irving Medical Center (US)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1186/s13058-025-01984-0
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Thompson Family Foundation
- National Institutes of Health
- National Cancer Institute